RWLK VS AZYO Stock Comparison
Performance
RWLK10/100
10/100
RWLK returned -33.16% in the last 12 months. Based on SPY's performance of -21.08%, its performance is below average giving it a score of 10 of 100.
AZYO10/100
10/100
AZYO returned -59.78% in the last 12 months. Based on SPY's performance of -8.75%, its performance is below average giving it a score of 10 of 100.
Analyst Price Targets
RWLK80/100
80/100
5 analysts offer 12-month price targets for RWLK. Together, they have an average target of 3, the most optimistic target put RWLK at 3 within 12-months and the most pessimistic has RWLK at 3.
AZYO
"Analyst Price Targets" not found for AZYO
Sentiment
RWLK70/100
70/100
RWLK had a bullish sentiment score of 69.59% across Twitter and StockTwits over the last 12 months. It had an average of 16.27 posts, 18.18 comments, and 54.60 likes per day.
AZYO75/100
75/100
AZYO had a bullish sentiment score of 75.46% across Twitter and StockTwits over the last 12 months. It had an average of 5.50 posts, 1.00 comments, and 1.50 likes per day.
Technicals
RWLK10/100
10/100
RWLK receives a 10 of 100 based on 14 indicators. 0 are bullish, 12 are bearish.
AZYO57/100
57/100
AZYO receives a 57 of 100 based on 14 indicators. 7 are bullish, 5 are bearish.
Earnings
RWLK10/100
10/100
RWLK has missed earnings 12 times in the last 20 quarters.
AZYO10/100
10/100
AZYO has missed earnings 7 times in the last 20 quarters.
Profit
RWLK10/100
10/100
Out of the last 20 quarters, RWLK has had 0 profitable quarters and has increased their profits year over year on 0 of them.
AZYO10/100
10/100
Out of the last 15 quarters, AZYO has had 0 profitable quarters and has increased their profits year over year on 0 of them.
Volatility
RWLK44/100
44/100
RWLK has had a lower than average amount of volatility over the last 12 months giving it a score of 44 of 100.
AZYO52/100
52/100
AZYO has had a higher than average amount of volatility over the last 12 months giving it a score of 51 of 100.
All score calculations are broken down here to help you make more informed investing decisions
ReWalk Robotics Ltd Summary
Nasdaq / RWLK
Healthcare
Medical Devices
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.
Aziyo Biologics, Inc. Class A Common Stock Summary
Nasdaq / AZYO
Healthcare
Medical Devices
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device. The company also provides cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and infants to repair pericardial structures; and VasCure, a patch material to repair or reconstruct the peripheral vasculature, including the carotid, renal, iliac, femoral, and tibial blood vessels for cardiovascular, vascular, and general surgeons. In addition, it offers Fiber VBM, ViBone, and OsteGro V that are human tissue-derived bone allografts designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated HADM designed to repair or replacement of damaged or inadequate integumental tissues. Further, the company provides contract manufacturing services for various products to corporate customers. It sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. The company was incorporated in 2015 and is headquartered in Silver Spring, Maryland.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Compare Similar Companies
Compare RWLK to other companies in the same or a similar industry.